The European Parliament has faced a call to arms over the treatment of chronic pain.
The Pain Proposal European Consensus Report, written by experts and policymakers and sponsored by drug giant Pfizer, said chronic pain could be costing Europe as much as €300bn annually. It added, while costs to healthcare systems are significant, nine-tenths of the burden falls on employers, families and taxpayers. The report found 21% of Europeans with chronic pain are unable to work, and of those who are, 61% said it had directly impacted their employment status. In addition, people with chronic pain in employment felt that their condition interfered with their ability to work effe...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes